Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-12-11 McDowell Caryn Gordon Chief Legal & Adm. Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-10 Holsinger Leslie Executive Vice President Option exercise +3,500 $0.27 $945 3,500
2020-12-10 Holsinger Leslie Executive Vice President Option exercise · Stock Option (Right to Buy) −3,500 106,794
2020-06-12 EPIQ Capital Group, LLC IA/Managing Member of 10% Owne Purchase +2,440 $44.06 $108K 2,860,967
2020-06-11 EPIQ Capital Group, LLC IA/Managing Member of 10% Owne Purchase +6,600 $44.32 $293K 2,858,527
2020-06-08 YOUNG KEVIN Director Grant or award · Stock Option (Right to Buy) +11,029 11,029
2020-06-08 Senner Christopher J. Director Grant or award · Stock Option (Right to Buy) +11,029 11,029
2020-06-08 RYAN UNA S Director Grant or award · Stock Option (Right to Buy) +11,029 11,029
2020-06-08 McLoughlin Margaret Director Grant or award · Stock Option (Right to Buy) +11,029 11,029
2020-06-08 Lamond David Director Grant or award · Stock Option (Right to Buy) +11,029 11,029
2020-06-04 Lamond David Director Purchase +13,609 $42.13 $573K 1,711,593
2020-06-04 Lamond David Director Purchase +10,642 $43.32 $461K 1,722,235
2020-06-04 Lamond David Director Purchase +24,874 $43.88 $1.1M 1,747,109
2020-06-03 PFIZER INC 10% owner Sale −370,000 $40.18 $14.9M 2,879,973
2020-05-27 Detke Michael J. Chief Medical Officer Option exercise +5,515 $6.91 $38K 28,261
2020-05-27 Detke Michael J. Chief Medical Officer Option exercise · Stock Option (Right to Buy) −5,515 104,091
2020-05-22 EPIQ Capital Group, LLC IA/Managing Member of 10% Owne Purchase +2,085 $55.90 $117K 2,851,927
2020-05-21 EPIQ Capital Group, LLC IA/Managing Member of 10% Owne Purchase +520 $55.80 $29K 2,849,842
2020-05-20 EPIQ Capital Group, LLC IA/Managing Member of 10% Owne Purchase +5,668 $58.00 $329K 2,848,905
2020-05-20 EPIQ Capital Group, LLC IA/Managing Member of 10% Owne Purchase +417 $57.22 $24K 2,849,322

Page 14 of 18 · 350 trades